ACUPUNCTURE & ELECTRO-THERAPEUTICS RESEARCH, published by COGNIZANT COMMUNICATION CORP, is a pivotal journal that delves into the intricate relationship between acupuncture, electro-therapeutics, and their applications in the fields of anesthesiology, pain medicine, and complementary therapies. With an ISSN of 0360-1293 and an E-ISSN of 2167-9010, this esteemed journal has been serving the academic community since 1976 and will continue to publish groundbreaking research until 2024. Despite its current positioning within the Q4 quartiles for both anesthesiology and complementary medicine, ACUPUNCTURE & ELECTRO-THERAPEUTICS RESEARCH remains a valuable platform for disseminating innovative studies that push the boundaries of traditional pain management and neuroscience. Researchers, students, and professionals interested in exploring contemporary therapeutic modalities will find this journal an indispensable resource for understanding the efficacy and applications of acupuncture and electro-therapeutics. With a focus on advancing knowledge in these domains, the journal aims to foster a deeper understanding of integrative approaches to health and wellness.

Current Stem Cell Research & Therapy, published by Bentham Science Publishers Ltd, is a leading journal dedicated to advancing the field of stem cell research. With an ISSN of 1574-888X and an E-ISSN of 2212-3946, this journal has been a valuable resource since its inception in 2006 and continues to broaden its scope through 2024. Recognized in the Q2 quartile for Medicine (miscellaneous) and ranked in the 66th percentile among its peers, the journal plays a crucial role in disseminating high-quality, peer-reviewed research that explores both the therapeutic and biological implications of stem cells. Located in the United Arab Emirates, Current Stem Cell Research & Therapy embraces a global audience of researchers, professionals, and students, providing a vibrant platform for discourse and innovation. While the journal offers subscription-based access, it remains committed to enhancing the scientific community's understanding of stem cell therapy and its applications across various medical fields.

Discovery Medicine, an esteemed journal published by Discovery Medicine, serves as a vital platform within the field of general medicine, dedicated to advancing knowledge through high-quality research and innovative insights. With its ISSN 1539-6509 and E-ISSN 1944-7930, this journal boasts an impressive Scopus ranking of #29 out of 529 in the general medicine category, positioning it at the 94th percentile, indicating its significant contribution to the medical sciences. While operating as a subscription-based journal, Discovery Medicine fosters an environment where researchers and professionals can disseminate their findings and engage with cutting-edge developments in medicine. Spanning topics that bridge clinical practice and healthcare advancements, this journal aims to inform, challenge, and inspire the medical community. The journal has converged its volumes from 2006 to 2007 and again from 2009 to 2018, highlighting its sustained commitment to excellence even as coverage has temporarily discontinued in Scopus. Situated at 10 Gerard Ave, Ste 201, Timonium, MD 21093, Discovery Medicine continues to be a cornerstone for medical scholars, offering a rich repository of knowledge essential for ongoing research and practical applications.

The Journal of Stem Cells & Regenerative Medicine is a leading publication dedicated to the advancing field of stem cell research and regenerative medicine. Established in India and published by JOURNAL STEM CELLS & REGENERATIVE MEDICINE, this Open Access journal has been available since 2007, providing researchers and practitioners with free and unrestricted access to high-quality articles. With an ISSN of 0973-7154, the journal is indexed in Scopus, featuring a wide array of topics and insights into biochemistry, biotechnology, cell biology, and molecular biology, as denoted by its relevant quartile rankings. This journal is committed to bridging the gap between laboratory research and clinical applications, making significant contributions to the scientific community. The convergence of innovative studies from 2010 to 2024 positions it as an invaluable resource for those looking to stay at the forefront of stem cell and regenerative medicine research.

Archives of Physiology and Biochemistry, published by Taylor & Francis Ltd, is a renowned journal that has been pivotal in advancing knowledge and research in the fields of physiology and biochemistry since its inception. With an impact factor reflective of its significant contributions, this journal is categorized in Q2 in Medicine (miscellaneous) and Q3 in Physiology, underscoring its relevance and scholarly impact within the scientific community. The journal publishes original research articles, review papers, and innovative methodologies that explore the intricate relationships between physiological functions and biochemical processes. With its commitment to fostering scientific discourse, the Archives of Physiology and Biochemistry serves as an essential resource for researchers, professionals, and students alike, providing insights and evidence that drive forward the frontiers of medical and physiological science. The journal is accessible in both print and online formats, ensuring that critical research reaches a wide audience.

Antioxidants is a premier open-access journal published by MDPI that has been actively contributing to the field of antioxidant research since its inception in 2012. Based in Switzerland, the journal holds a noteworthy impact factor indicative of its scholarly influence, particularly given its high rankings in various categories. As of 2023, it proudly sits in the Q1 quartile in Biochemistry, Clinical Biochemistry, Food Science, and Physiology, solidifying its status as a critical resource for innovative studies. With a strong focus on the roles of antioxidants across multiple disciplines—ranging from molecular biology to food science—this journal serves as a vital platform for researchers, professionals, and students aiming to advance knowledge in mitigating oxidative stress and enhancing health through dietary and therapeutic approaches. The open-access model guarantees wide accessibility, allowing for the dissemination of significant research findings globally, making it indispensable for anyone engaged in modern biochemical and physiological studies.

The European Journal of Pharmacology, a prestigious publication by Elsevier, serves as a vital resource in the field of pharmacology, offering rich insights into drug development and therapeutic applications. Since its inception in 1967, this journal has evolved to encompass groundbreaking research, including pharmacokinetics, toxicology, and innovative pharmacological methodologies, making it an essential platform for researchers and professionals alike. With an impressive impact factor that places it in the Q1 category of pharmacological journals and a Scopus ranking of #49 out of 313, the journal is recognized in the 84th percentile within its category, solidifying its significance in the academic community. Although the journal is not open access, it continues to attract contributions from leading scientists worldwide, ensuring that cutting-edge findings are disseminated effectively. The European Journal of Pharmacology not only highlights advancements in drug discovery and clinical applications but also promotes interdisciplinary collaboration, ultimately contributing to the progress of healthcare globally.

Inhalation Toxicology, published by Taylor & Francis Ltd, is a premier journal dedicated to advancing the field of toxicology with a particular focus on inhalation exposure and its impact on human health. Established in 1989, this journal provides a vital platform for original research, reviews, and case studies that explore the toxicological effects of inhaled substances, making it essential reading for researchers, health professionals, and regulatory scientists. With an Impact Factor that situates it in the Q3 category in both Health, Toxicology and Mutagenesis, the journal asserts its relevance within the scientific community, particularly emphasizing its contributions as indexed by Scopus rankings in related fields. Although it follows a traditional access model, the journal's commitment to delivering high-quality research continues to foster significant discussions and advancements in understanding inhalation toxicology. For those at the forefront of environmental science and pharmacology, Inhalation Toxicology is an indispensable resource for both current research and future innovations in the discipline.

Undersea and Hyperbaric Medicine is a pivotal journal published by the Undersea & Hyperbaric Medical Society Inc., focusing on the advanced field of undersea and hyperbaric medical research. It has served the scientific community since its inception in 1993, and is recognized for its commitment to disseminating peer-reviewed articles that address both the clinical and scientific aspects of hyperbaric medicine and related disciplines. The journal is indexed in various databases and classified in key quartiles, ranking Q3 in Medicine (miscellaneous) and Q4 in Physiology (medical) as of 2023, making it an essential resource for professionals engaged in these specialized areas. Although the journal does not currently offer open access, its implications and contributions to the fields of pulmonary and respiratory medicine and physiology are substantial, with a Scopus rank indicating its relevance despite some competitive challenges. This publication serves as a vital platform for researchers, allows for the exploration of novel therapies, and promotes the dissemination of knowledge critical for advancements in medical practice related to undersea and hyperbaric environments.

Photobiomodulation Photomedicine and Laser Surgery is a premier peer-reviewed journal published by MARY ANN LIEBERT, INC, dedicated to advancing the understanding of light-based therapies in biomedical applications. With an impressive impact factor, this journal occupies a significant position in the field of Biomedical Engineering and Radiology, Nuclear Medicine and Imaging, evidenced by its placement in the Q3 category for both fields as of 2023. The journal's scope encompasses a wide array of research topics, including but not limited to, the therapeutic effects of photobiomodulation and innovative laser surgical techniques. Researchers and practitioners alike can benefit from its open-access format, facilitating the dissemination of cutting-edge findings to a global audience. By bridging the gap between scientific inquiry and clinical application, Photobiomodulation Photomedicine and Laser Surgery plays a crucial role in fostering the integration of advanced technologies in healthcare, enhancing patient outcomes and pushing the boundaries of medical science.